Skip to content

Sarepta Therapeutics, Inc. SRPT Payments to Acquire Intangible Assets

Payments to Acquire Intangible Assets at other companies

Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$170.94K+273%
ESN
Essent GroupESNT
$0-100%
Rumble, Inc. logo
Rumble, Inc.RUM
$1.16M+89.1%
Trex Company logo
Trex CompanyTREX
$1.85M+192%
ADMA Biologics logo
ADMA BiologicsADMA
$53K+179%
Zymeworks logo
ZymeworksZYME
$0-100%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s payments to acquire intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s payments to acquire intangible assets?
Sarepta Therapeutics, Inc. (SRPT) reported payments to acquire intangible assets of $1M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s payments to acquire intangible assets changed year-over-year?
Sarepta Therapeutics, Inc.'s payments to acquire intangible assets decreased by 55.3% year-over-year, from $2.24M to $1M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s payments to acquire intangible assets?
Over 2 years (2021 to 2025), Sarepta Therapeutics, Inc.'s payments to acquire intangible assets has grown at a 84.7% compound annual growth rate (CAGR), from $2.31M to $7.88M.